We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600096:SSEYunnan Yuntianhua Co. Ltd. Class A Analysis

Data as of 2026-03-17 - not real-time

CN¥39.17

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Yunnan Yuntianhua (600096.SS) is trading at CNY 39.17, comfortably above its 50‑day SMA of 37.75 but still beneath the 20‑day SMA of 40.80, indicating a short‑term bullish bias that is tempered by a bearish MACD histogram and a neutral RSI near 47. The stock sits near its identified support at 35.24 and faces resistance around 45.62, while a high 30‑day volatility of roughly 63 % and a very low computed beta (~0.13) suggest price swings are pronounced yet largely detached from broader market moves. Relative to the DCF‑derived fair value of CNY 32.98, the market price appears overvalued, though the forward P/E of 12.16 remains modest.
Fundamentally, the company posted a 14.4 % revenue decline yet maintains solid profitability with a 10.8 % net margin, a 24 % ROE and a healthy operating cash flow of CNY 11.1 bn, supporting a generous dividend yield of 3.93 % and a payout ratio of 52 %, which we deem sustainable. The balance sheet shows a debt‑to‑equity of 54 % and cash reserves covering roughly half of total debt, limiting financial strain. Operating in the basic‑materials sector, Yuntianhua faces moderate regulatory and geographic risks tied to Chinese fertilizer policies, but its low currency exposure and strong liquidity mitigate many concerns.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above 50‑day SMA but below 20‑day SMA
  • Bearish MACD histogram and high short‑term volatility
  • Support level at 35.24 provides downside cushion

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Current price exceeds DCF fair value, suggesting limited upside
  • Stable cash flow and attractive dividend yield
  • Revenue contraction of 14.4% raises growth concerns

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong ROE (~24%) and solid dividend sustainability
  • Low beta indicating defensive characteristics
  • Potential price correction toward DCF valuation

Key Metrics & Analysis

Financial Health

Revenue Growth-14.40%
Profit Margin10.76%
P/E Ratio12.7
ROE24.06%
ROA8.71%
Debt/Equity54.06
P/B Ratio2.9
Op. Cash FlowCN¥11.1B
Free Cash FlowCN¥5.0B

Technical Analysis

TrendBullish
RSI47.3
SupportCN¥35.24
ResistanceCN¥45.62
MA 20CN¥40.80
MA 50CN¥37.75
MA 200CN¥29.42
MACDBearish
VolumeIncreasing
Fear & Greed Index78.46

Valuation

Fair ValueCN¥32.98
GradeOvervalued
TypeValue
Dividend Yield3.93%

Risk Assessment

Beta0.13
Volatility63.17%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.